ViroPharma, Inc

Published Date: 30/01/2012
Category: Therapies & Markets

Research Report Decription

ViroPharma Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.

Features:

• Detailed information on ViroPharma Incorporated required for business and competitor intelligence needs
• A study of the major internal and external factors affecting ViroPharma Incorporated in the form of a SWOT analysis
• An in-depth view of the business model of ViroPharma Incorporated including a breakdown and examination of key business segments
• Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for ViroPharma Incorporated
• Intelligence on ViroPharma Incorporated nv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about ViroPharma Incorporated, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Key Questions Answered:

• Gain understanding of the ViroPharma Inc. and the factors that influence its strategies
• Track strategic initiatives of the company and latest corporate news and actions
• Assess ViroPharma Incorporated as a prospective partner, vendor or supplier
• Support sales activities by understanding your customers' businesses better
• Stay up to date on ViroPharma Incorporated’s business structure, strategy and prospects

Companies Mentioned:

ViroPharma Inc.

Paper Highlights:

ViroPharma is a global biotechnology company dedicated to the development and commercialization of products that address serious diseases. The company is headquartered in Exton, Pennsylvania and employed 232 people as of December 31, 2010.  The company recorded revenues of $439 million during the financial year ended December 2010 (FY2010), an increase of 41.4% over FY2009. The operating profit of the company was $211.7 million during FY2010, as compared to operating profit of $32.1 million in FY2009. The net profit was $125.6 million in FY2010, as compared to net loss of $11.1 million in FY2009.